The FTSE 100 looked anything but sharp in afternoon trading on Friday, slipping 56 to finish at 5, 258.
The Shire Pharmaceutical company was down 35 points today on the news that the FDA of America delayed an important publication about the possible cardiac issues associated with attention deficit hyperactivity disorder (ADHD) drugs until early next year. Analysts believe this will give the stock time to recover and there was a great chance the report will clear up any concerns about the safety of this drug.
Other sliders of the day included miners, retail, and leisure stocks.
Lloyd’s GRP was the volume leader. They were followed by Vodafone GRP, RBS, Barclays and BP respectively.